Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Veerle Surmont
Profile
Projects
Publications
Activities
Awards & Distinctions
80
Results
2024
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
Joline Ingels
Laurenz De Cock
Dieter Stevens
Rupert Mayer
Fabien Henri Thery
Guillem Sanchez Sanchez
David Vermijlen
Karin Weening
SASKIA DE SMET
NELE LOOTENS
et al.
A1
Journal Article
in
CELL REPORTS MEDICINE
2024
2023
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial
Mathieu Spaas
Nora Sundahl
Vibeke Kruse
Sylvie Rottey
Daan De Maeseneer
Fréderic Duprez
Yolande Lievens
Veerle Surmont
Lieve Brochez
Dries Reynders
et al.
A1
Journal Article
in
JAMA ONCOLOGY
2023
Impact of cancer treatment on physical performance in early-stage non-small cell lung cancer
Kirsten Quadflieg
Eva Arents
Sarah Haesevoets
Fien Hermans
Maarten Criel
Marc Daenen
David Ruttens
Michiel Thomeer
Martijn A. Spruit
Dieter Stevens
et al.
C3
Conference
2023
Physical performance of non-small cell lung cancer patients 3 months post treatment initiation compared to healthy peers
Eva Arents
Kirsten Quadflieg
Sarah Haesevoets
Fien Hermans
Maarten Criel
Marc Daenen
Eric Derom
David Ruttens
Martijn A. Spruit
Dieter Stevens
et al.
C3
Conference
2023
2022
Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome
Malaïka Van der Linden
Bram Van Gaever
Lennart Raman
Karim Vermaelen
Ingel Demedts
Veerle Surmont
Ulrike Himpe
Yolande Lievens
Liesbeth Ferdinande
Franceska Dedeurwaerdere
et al.
A1
Journal Article
in
CANCERS
2022
Health-related quality of life, toxicity and neuro-cognitive functioning : what matters to non-small cell lung cancer patients?
Lotte van der Weijst
Yolande Lievens
Veerle Surmont
Dissertation
2022
Neurocognitive functioning following lung cancer treatment : the PRO-Long study
Lotte van der Weijst
Yolande Lievens
Veerle Surmont
Wim Schrauwen
A2
Journal Article
in
TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY
2022
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
Lotte van der Weijst
Miguel E. Aguado-Barrera
David Azria
Patrick Berkovic
Pierre Boisselier
Erik Briers
Renée Bultijnck
Patricia Calvo-Crespo
Jenny Chang-Claude
Ananya Choudhury
et al.
A1
Journal Article
in
LUNG CANCER
2022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study
Lotte van der Weijst
David Azria
Patrick Berkovic
Pierre Boisselier
Erik Briers
Renée Bultijnck
Jenny Chang-Claude
Ananya Choudhury
Gilles Defraene
Sylvian Demontois
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2022
2021
Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation : a case report
Lander Van Acker
Dieter Stevens
Karim Vermaelen
Veerle Surmont
A2
Journal Article
in
JOURNAL OF MEDICAL CASE REPORTS
2021
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial
Mathieu Spaas
Nora Sundahl
Eva Hulstaert
Vibeke Kruse
Sylvie Rottey
Daan De Maeseneer
Veerle Surmont
Annabel Meireson
Lieve Brochez
Dries Reynders
et al.
A1
Journal Article
in
BMC CANCER
2021
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials
Solange Peters
Sarah Danson
Dunson Ejedepang
Urania Dafni
Baktiar Hasan
Hoi-Shen Radcliffe
Frederique Bustin
Jacky Crequit
Linda Coate
Monica Guillot
et al.
A1
Journal Article
in
LUNG CANCER
2021
Coping strategy influences quality of life in patients with advanced lung cancer by mediating mood
Mick van de Wiel
Sofie Derijcke
Daniella Galdermans
Marc Daenen
Veerle Surmont
Els De Droogh
Anneke Lefebure
Erika Saenen
Elke Vandenbroucke
Ann-Marie Morel
et al.
A1
Journal Article
in
CLINICAL LUNG CANCER
2021
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial
Mathieu Spaas
Nora Sundahl
Sylvie Rottey
VIBEKE KRUSE
Daan De Maeseneer
Fréderic Duprez
Piet Dirix
Veerle Surmont
Yolande Lievens
Robin Van den Begin
et al.
C3
Conference
2021
Lung cancer in Belgium
Sebahat Ocak
Kurt Tournoy
Thierry Berghmans
Ingel Demedts
Rodolphe Durieux
Annelies Janssens
Luigi Moretti
Kristiaan Nackaerts
Thierry Pieters
Veerle Surmont
et al.
Editorial material
2021
Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study
Lotte van der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2021
2020
A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)
M. Reck
K. F. Mileham
D. A. Clump
L. Decoster
A. Estival
E. Felip
P. Fried
L. Paz-Ares
M. Sebastian
N Vinolas Segarra
et al.
C3
Conference
2020
Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer : results from the Belgian compassionate use program
Sofie Joris
Thierry Pieters
Anne Sibille
Frederique Bustin
Laurence Jacqmin
Hassan Rezaei Kalantari
Veerle Surmont
Jean-Charles Goeminne
Frederic Clinckart
Karin Pat
et al.
A1
Journal Article
in
JOURNAL OF GERIATRIC ONCOLOGY
2020
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma
Lennart Raman
Malaïka Van der Linden
Kim Van der Eecken
Karim Vermaelen
Ingel Demedts
Veerle Surmont
Ulrike Himpe
Franceska Dedeurwaerdere
Liesbeth Ferdinande
Yolande Lievens
et al.
A1
Journal Article
in
GENOME MEDICINE
2020
The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life : a randomised controlled trial
Gaëlle Vanbutsele
Simon Van Belle
Veerle Surmont
MARTINE DE LAAT
Roos Colman
Kim Eecloo
Eline Naert
Marc De Man
Karen Geboes
Luc Deliens
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2020
2019
Coping strategy influences quality of life in patients with advanced lung cancer
Annelies Janssens
Sofie Derijcke
Danny Galdermans
Veerle Surmont
Els De Droogh
Anneke Lefebure
Erika Saenen
Elke Vandenbroucke
Ann-Marie Morel
Anna Sadowska
et al.
C3
Conference
2019
Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC
Fabrice Barlesi
Edward B. Garon
Dong-Wan Kim
Enriqueta Felip
Ji-Youn Han
Joo-Hang Kim
Myung-Ju Ahn
Mary Jo Fidler
Matthew A. Gubens
Jr. de Castro, Gilberto
et al.
A1
Journal Article
in
JOURNAL OF THORACIC ONCOLOGY
2019
Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC (vol 14, pg 793, 2019)
F. Barlesi
E. B. Garon
D-W Kim
F. Enriqueta
J.Y. Han
J.H. Kim
M.J. Ahn
M.J. Fidler
M.A. Gubens
G. de Castro
et al.
Correction
2019
Health-related quality of life in advanced non-small cell lung cancer : a methodological appraisal based on a systematic literature review
Lotte van der Weijst
Yolande Lievens
Wim Schrauwen
Veerle Surmont
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2019
Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study
Lotte van der Weijst
Renée Bultijnck
Axel Van Damme
Marc Van Eijkeren
Veerle Surmont
Yolande Lievens
C3
Conference
2019
Prognostic understanding and quality of life in patients with advanced lung cancer : a multicenter study
Annelies Janssens
Sofia Derijcke
Danielle Galdermans
Marc Daenen
Veerle Surmont
Els De Droogh
Anneke Lefebure
Erika Saenen
Elke Vandenbroucke
Ann-Marie Morel
et al.
A1
Journal Article
in
CLINICAL LUNG CANCER
2019
Real-world neurocognitive function in lung cancer : initial results of the PRO-Long study.
Lotte van der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens
C3
Conference
2019
Staging of nutrition disorders in non-small-cell lung cancer patients : utility of skeletal muscle mass assessment
Sami Antoun
Hugues Morel
Pierre-Jean Souquet
Veerle Surmont
David Planchard
Franck Bonnetain
Pascal Foucher
Thomas Egenod
Ivan Krakowski
Helene Gaudin
et al.
A1
Journal Article
in
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2019
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival : an updated analysis of KEYNOTE-010 trial
RS Herbst
P Baas
JL Perez-Gracia
E Felip
D-W Kim
J-Y Han
JR Molina
J-H Kim
C Dubos Arvis
M-J Ahn
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2019
2018
A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205)
Jo Raskin
Veerle Surmont
Robin Cornelissen
Paul Baas
Paul EY van Schil
Jan P van Meerbeeck
A1
Journal Article
in
TRANSLATIONAL LUNG CANCER RESEARCH
2018
Effect of early and systematic integration of palliative care in patients with advanced cancer : a randomised controlled trial
Gaëlle Vanbutsele
Koen Pardon
Simon Van Belle
Veerle Surmont
MARTINE DE LAAT
Roos Colman
Kim Eecloo
Veronique Cocquyt
Karen Geboes
Luc Deliens
A1
Journal Article
in
LANCET ONCOLOGY
2018
Effect of early palliative care : complex intervention and complex results : authors' reply
Gaëlle Vanbutsele
Koen Pardon
Simon Van Belle
Veerle Surmont
MARTINE DE LAAT
Roos Colman
Kim Eecloo
Veronique Cocquyt
Karen Geboes
Luc Deliens
A1
Journal Article
in
LANCET ONCOLOGY
2018
Invasive aspergillosis mimicking metastatic lung cancer
Michiel Vanfleteren
Anne-Marie C Dingemans
Veerle Surmont
Karim Vermaelen
Alida A Postma
Astrid ML Oude lashof
Cordula CM Pitz
Lizza EL Hendriks
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2018
2017
A middle-aged woman with a heavy heart
Cedric Van de Bruaene
Lara Crapé
Veerle Surmont
Editorial material
2017
Adaptive radiotherapy for locally advanced non-small cell lung cancer : dosimetric gain and treatment outcome prediction
PATRICK BERKOVIC
Leen Paelinck
Akos Gulyban
Marc Van Eijkeren
Veerle Surmont
Yolande Lievens
Katrien Vandecasteele
A1
Journal Article
in
ACTA ONCOLOGICA
2017
Addressing the palliative setting in advanced lung cancer should not remain a barrier : a multicenter study
Annelies Janssens
Sofie Derijcke
Anneke Lefebure
Elke Vandenbroucke
Veerle Surmont
Dieter Coeman
Daniëlle Galdermans
Ann-Marie Morel
Birgitta I Hiddinga
Jan P van Meerbeeck
A2
Journal Article
in
CLINICAL LUNG CANCER
2017
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial
Corinne Faivre-Finn
Michael Snee
Linda Ashcroft
Wiebke Appel
Fabrice Barlesi
Adityanarayan Bhatnagar
Andrea Bezjak
Felipe Cardenal
Pierre Fournel
Susan Harden
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2017
Health-related quality of life reporting in lung cancer trials : a methodological appraisal
Lotte van der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens
C3
Conference
2017
Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer : has it yet become state-of-the-art?
Lotte van der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2017
2016
Development of a blood test for selection of lung cancer patients who could benefit from immunotherapy.
Malaïka Van der Linden
Karim Vermaelen
Ingel Demedts
Veerle Surmont
Kathleen Claes
Björn Menten
Jo Van Dorpe
C3
Conference
2016
Palliative care needs at different phases in the illness trajectory : a survey study in patients with cancer
Kim Beernaert
Koen Pardon
Lieve Van den Block
Dirk Devroey
Martine De Laat
Karen Geboes
Veerle Surmont
Luc Deliens
Joachim Cohen
C3
Conference
2016
Palliative care needs at different phases in the illness trajectory : a survey study in patients with cancer
Kim Beernaert
Koen Pardon
Lieve Van den Block
D Devroey
MARTINE DE LAAT
Karen Geboes
Veerle Surmont
Luc Deliens
Joachim Cohen
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER CARE
2016
Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment
Roy S Herbst
Paul Baas
Jose L Perez-Gracia
Enriqueta Felip
Dong-Wan Kim
Ji-Youn Han
Julian Molina
Joo-Hang Kim
Catherine Dubos Arvis
Myung-Ju Ahn
et al.
C3
Conference
2016
Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment
Roy S Herbst
Paul Baas
Jose L Perez-Gracia
Enriqueta Felip
Dong-Wan Kim
Ji-Youn Han
Julian Molina
Joo-Hang Kim
Catherine Dubos Arvis
Myung-Ju Ahn
et al.
C3
Conference
2016
Quality of life in locally-advanced non-small cell lung cancer patients : a systematic review
Lotte van der Weijst
Wim Schrauwen
Veerle Surmont
Yolande Lievens
C3
Conference
2016
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)
Fatma Abdelraouf
Egbert Smit
Baktiar Hasan
Jessica Menis
Sanjay Popat
Jan Van Meerbeeck
Veerle Surmont
Paul Baas
Mary O'Brien
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2016
2015
A phase I study of volasertib combined with afatinib, in advanced solid tumors
Jean-Pascal Machiels
Marc Peeters
Catherine Herremans
Veerle Surmont
Pol Specenier
Marina De Smet
Korinna Pilz
Natalja Strelkowa
Dan Liu
Sylvie Rottey
A1
Journal Article
in
CANCER CHEMOTHERAPY AND PHARMACOLOGY
2015
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
PATRICK BERKOVIC
Leen Paelinck
Yolande Lievens
Akos Gulyban
BRUNO GODDEERIS
CRISTINA DERIE
Veerle Surmont
Wilfried De Neve
Katrien Vandecasteele
A1
Journal Article
in
ACTA ONCOLOGICA
2015
Maintenance pazopanib versus placebo in non-small cell lung cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)
Mary ER O'Brien
Rabab Gaafar
Baktiar Hasan
Jessica Menis
Tanja Cufer
Sanjay Popat
Penella J Woll
Veerle Surmont
Vassilis Georgoulias
Ana Montes
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2015
Rehabilitation in patients with radically treated respiratory cancer : a randomised controlled trial comparing two training modalities
Bihiyga Salhi
Christel Haenebalcke
Silvia Perez-Bogerd
Mai D Nguyen
Vincent Ninane
THOMAS MALFAIT
Karim Vermaelen
Veerle Surmont
Georges Van Maele
Roos Colman
et al.
A1
Journal Article
in
LUNG CANCER
2015
The systematic early integration of palliative care into multidisciplinary oncology care in the hospital setting (IPAC), a randomized controlled trial : the study protocol
Gaëlle Vanbutsele
Simon Van Belle
MARTINE DE LAAT
Veerle Surmont
Karen Geboes
Kim Eecloo
Koen Pardon
Luc Deliens
A1
Journal Article
in
BMC HEALTH SERVICES RESEARCH
2015
Unresectable stage III non-small-cell lung cancer : have we made any progress?
CAROLIEN DE TOLLENAERE
Yolande Lievens
Katrien Vandecasteele
Karim Vermaelen
Veerle Surmont
A2
Journal Article
in
WORLD JOURNAL OF RESPIROLOGY
2015
2014
EGFR mutation positive stage IV non small-cell lung cancer: treatment beyond progression
KATRIJN VAN ASSCHE
Liesbeth Ferdinande
Yolande Lievens
Katrien Vandecasteele
Veerle Surmont
A2
Journal Article
in
FRONTIERS IN ONCOLOGY
2014
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
Hasan Baktiar
Laurent Greillier
Athanasios Pallis
Jessica Menis
Rabab Gaafar
Richard Sylvester
Dean A Fennell
Paul Baas
Veerle Surmont
Jan Van Meerbeeck
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2014
The effect of radical treatment and rehabilitation on muscle mass and strength: a randomized trial in stages I-III lung cancer patients
Bihiyga Salhi
Wouter Huysse
Georges Van Maele
Veerle Surmont
Eric Derom
Jan Van Meerbeeck
A1
Journal Article
in
LUNG CANCER
2014
2013
Management of malignant pleural mesothelioma: have we made any progress?
BIRGITTA HIDDINGA
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
PANMINERVA MEDICA
2013
Outcome and prognostic factors of bronchopulmonary neuroendocrine tumors (BNETS): a single institutional series
Charlotte Verroken
BIRGITTA HIDDINGA
Liesbeth Ferdinande
Veerle Surmont
FREDERIC DE RYCK
Karim Vermaelen
Karen Geboes
Jan Van Meerbeeck
C3
Conference
2013
Resistance training in patients with radically treated respiratory cancer: a prospective randomized multi-center study (REINFORCE)
Jan Van Meerbeeck
Bihiyga Salhi
C Haenebalcke
S Perez-Bogerd
MD Nguyen
Thomas Malfait
Karim Vermaelen
Veerle Surmont
Georges Van Maele
Eric Derom
C3
Conference
2013
Resistance training in patients with radically treated respiratory cancer: mature results of a multi-centre randomised phase 3 trial (REINFORCE)
Jan Van Meerbeeck
Bihiyga Salhi
Christel Haenebalcke
Sylvia Perez-Bogerd
May D Nguyen
Thomas Malfait
Karim Vermaelen
Veerle Surmont
Georges Van Maele
Roos Colman
et al.
C3
Conference
2013
Second opinion for thoracic cancer and its impact on diagnosis and treatment strategy: a single institutional series
Thomas Malfait
Veerle Surmont
Birgitta I Hiddinga
Karim Vermaelen
Jan Van Meerbeeck
C3
Conference
2013
2012
Activating EGFR mutations in patients with non small cell lung cancer: prevalence and predictors in a caucasian series
Thomas Malfait
Liesbeth Ferdinande
Kurt Tournoy
D Galdermans
Marleen Praet
Veerle Surmont
Ramses Forsyth
Karim Vermaelen
Jan Van Meerbeeck
C3
Conference
2012
Effect of radical treatment on exercise capacity and muscle force in patients with intrathoracic cancer
Bihiyga Salhi
Charlotte Haenebalcke
S Perez-Bogerd
M Nguyen
Karim Vermaelen
Veerle Surmont
Jan Van Meerbeeck
Eric Derom
C3
Conference
2012
Feasibility of epidermal growth factor receptor mutation testing in cytology samples
Thomas Malfait
Liesbeth Ferdinande
Jan Van Meerbeeck
D Galdermans
Veerle Surmont
Ramses Forsyth
Karim Vermaelen
Marleen Praet
Kurt Tournoy
C3
Conference
2012
Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future
Mary ER O'Brien
Jan Van Meerbeeck
Veerle Surmont
Corinne Faivre Finn
A2
Journal Article
in
EUROPEAN JOURNAL OF CANCER. SUPPLEMENTS
2012
Treatment of metastatic non-small cell lung cancer: standard of care and future perspectives
Veerle Surmont
Jan Van Meerbeeck
A2
Journal Article
in
MINERVA PNEUMOLOGICA
2012
2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
Rabab M Gaafar
Veerle Surmont
Giorgio V Scagliotti
Rob J Van Klaveren
Demetris Papamichael
John J Welch
Baktiar Hasan
Valter Torri
Jan Van Meerbeeck
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2011
Investigational approaches for mesothelioma
Veerle Surmont
Eric RE Van Thiel
Karim Vermaelen
Jan Van Meerbeeck
A2
Journal Article
in
FRONTIERS IN ONCOLOGY
2011
Malignant pleural mesothelioma: the standard of care and challenges for future management
Jan Van Meerbeeck
Arnaud Scherpereel
Veerle Surmont
Paul Baas
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2011
Malignant pleural mesothelioma: when is radiation therapy indicated?
ERE van Thiel
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
EXPERT REVIEW OF ANTICANCER THERAPY
2011
Raltitrexed in mesothelioma
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
EXPERT REVIEW OF ANTICANCER THERAPY
2011
2010
18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours
Daan De Maeseneer
Bieke Lambert
Veerle Surmont
Karen Geboes
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2010
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer
Veerle Surmont
JGJV Aerts
RJ van Klaveren
K Tournoy
KY Tan
RM Vernhout
PIM Schmitz
C Legrand
HC Hoogsteden
JP van Meerbeeck
A1
Journal Article
in
ONCOLOGY
2010
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer
SOFIE DE CRAENE
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
CURRENT OPINION IN ONCOLOGY
2010
Endurance and resistance training in radically treated respiratory cancer patients: a pilot study
Bihiyga Salhi
Ingel Demets
Ann Simpelaere
Sofie Decraene
Karim Vermaelen
Veerle Surmont
Jan Van Meerbeeck
Eric Derom
A2
Journal Article
in
REHABILITATION RESEARCH AND PRACTICE
2010
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies
Veerle Surmont
EF Smit
M de Jonge
JG Aerts
K Nackaerts
R Vernhout
J Gras
A Van Wijk
ECJ Phernambucq
JP van Meerbeeck
et al.
A1
Journal Article
in
LUNG CANCER
2010
2009
Epidermal growth factor receptor protein expression and gene amplification in Caucasian patients with malignant pleural mesothelioma (MPM)
Veerle Surmont
Marleen Praet
Isabelle Rottiers
ELISABETH BEERENS
BART MATTHYS
Patrick Pauwels
Jan Van Meerbeeck
C3
Conference
2009
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study
Veerle Surmont
Joachim Aerts
E Pouw
K Tan
R Vernhout
J Gras
J Salome
T Pronk
P Schmitz
H Hoogsteden
et al.
A1
Journal Article
in
LUNG CANCER
2009
Stage IIIA-N2 NSCLC: A review of its treatment approaches and future developments
Jan Van Meerbeeck
Veerle Surmont
A1
Journal Article
in
LUNG CANCER
2009
Trimodality treatment of early stage Malignant Pleural Mesothelioma (MPM): a single institutional experience
Elke Vandenbroucke
Marleen Praet
Karim Vermaelen
Veerle Surmont
FREDERIC DE RYCK
Kurt Tournoy
Robert Gosselin
Wilfried De Neve
Frank Vermassen
Jan Van Meerbeeck
C3
Conference
2009
What is the role for surgery in patients with stage III non-small cell lung cancer ?
Elke Vandenbroucke
FREDERIC DE RYCK
Veerle Surmont
Jan Van Meerbeeck
A1
Journal Article
in
Current Opinion in Pulmonary Medicine
2009